antiviral therapies that have been specifically approved to treat ZIKV, and there is an urgent need to develop effective anti-ZIKV agents. Here, we report anti-ZIKV activity of 16 synthetic carbohydrate receptors (SCRs) that inhibit ZIKV infection in Vero and HeLa cells. Using a ZIKV reporter virus particle-based infection assay, our data demonstrates these SCRs are highly potent with IC50s as low as
寨卡病毒(ZIKV)是一种蚊子传播的黄病毒,由于与严重的神经系统疾病有关,因此引起了全球健康的关注。当前,尚无专门批准用于治疗ZIKV的抗病毒疗法,并且迫切需要开发有效的抗ZIKV药物。在这里,我们报告了16种合成
碳水化合物受体(SCR)的抗ZIKV活性,这些受体可抑制Vero和HeLa细胞中的ZIKV感染。使用基于ZIKV报道分子病毒的感染分析,我们的数据表明,这些SCR具有很强的效力,IC50低至0.16μM,在几倍高的浓度下毒性却可以忽略不计。添加时间研究表明,这些SCR可抑制病毒感染的早期阶段,这与拟议的作用方式一致,